您当前的位置：
首页 >
文章列表页 >
Efficacy and safety comparison of dupilumab versus thalidomide in the treatment of refractory prurigo nodularis in adults
更新时间：2025-11-10

    • Efficacy and safety comparison of dupilumab versus thalidomide in the treatment of refractory prurigo nodularis in adults

    • “According to the latest research, Dupilumab is significantly more effective than thalidomide in treating refractory nodular prurigo in adults, and has good safety.”
    • ZHONGGUO YAOFANG   Vol. 36, Issue 21, Pages: 2687-2691(2025)

    • DOI：10.6039/j.issn.1001-0408.2025.21.12    

      CLC： R969.4;R751

    • Received：20 May 2025，

      Revised：2025-09-18，

      Accepted：18 September 2025，

      Published：15 November 2025

    移动端阅览

  • ZHANG Jianbo,HU Lei,HUANG Hegui,et al.Efficacy and safety comparison of dupilumab versus thalidomide in the treatment of refractory prurigo nodularis in adults[J].ZHONGGUO YAOFANG,2025,36(21):2687-2691. DOI： 10.6039/j.issn.1001-0408.2025.21.12.

  •  
  •  

0

Views

0

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Advances in the clinical application and safety of bispecific antibodies for cancer therapy
Efficacy and safety of ruxolitinib in the treatment of myelofibrosis
Clinical observation of doxycycline in the treatment of macrolide-unresponsive Mycoplasma pneumoniae pneumonia in children under 8 years of age
Meta-analysis of the efficacy and safety of PD-1/PD-L1 inhibitors combined with bevacizumab in the treatment of advanced non-small cell lung cancer
Clinical observation of vonoprazan-based triple therapy in treatment-naive patients with Helicobacter pylori infection

Related Author

LIN Mengmeng
LIN Xu
WANG Yixuan
JIANG Danna
SHI Shanshan
LI Yangling
WANG Wanwan
YE Jun

Related Institution

Dept. of Clinical Pharmacy， Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province， Affiliated Hangzhou First People’s Hospital， School of Medicine， Westlake University
Dept. of Thoracic Surgery， the First Affiliated Hospital， Zhejiang University School of Medicine
School of Pharmaceutical Sciences， Zhejiang Chinese Medical University
School of Pharmaceutical Sciences， Wenzhou Medical University
Dept. of Hematology， the Third People’s Hospital of Bengbu
0